APOA1 and amyloidosis: Notwithstanding the inconsistent evidence around HDL cholesterol levels in association with dementia risk,2,32,33 ApoA, and its ratio with HDL cholesterol, may be important indicators to be included in risk assessment, with previous experimental studies suggesting ApoA is also involved in amyloid pathology and astrocyte reactivity.34